{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:36:01Z","timestamp":1793741761786,"version":"4.6.1"},"reference-count":160,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The present review aimed to establish an understanding of the pathophysiology of leptomeningeal disease as it relates to late-stage development among different cancer types. For our purposes, the focused metastatic malignancies include breast cancer, lung cancer, melanoma, primary central nervous system tumors, and hematologic cancers (lymphoma, leukemia, and multiple myeloma). Of note, our discussion was limited to cancer-specific leptomeningeal metastases secondary to the aforementioned primary cancers. LMD mechanisms secondary to non-cancerous pathologies, such as infection or inflammation of the leptomeningeal layer, were excluded from our scope of review. Furthermore, we intended to characterize general leptomeningeal disease, including the specific anatomical infiltration process\/area, CSF dissemination, manifesting clinical symptoms in patients afflicted with the disease, detection mechanisms, imaging modalities, and treatment therapies (both preclinical and clinical). Of these parameters, leptomeningeal disease across different primary cancers shares several features. Pathophysiology regarding the development of CNS involvement within the mentioned cancer subtypes is similar in nature and progression of disease. Consequently, detection of leptomeningeal disease, regardless of cancer type, employs several of the same techniques. Cerebrospinal fluid analysis in combination with varied imaging (CT, MRI, and PET-CT) has been noted in the current literature as the gold standard in the diagnosis of leptomeningeal metastasis. Treatment options for the disease are both varied and currently in development, given the rarity of these cases. Our review details the differences in leptomeningeal disease as they pertain through the lens of several different cancer subtypes in an effort to highlight the current state of targeted therapy, the potential shortcomings in treatment, and the direction of preclinical and clinical treatments in the future. As there is a lack of comprehensive reviews that seek to characterize leptomeningeal metastasis from various solid and hematologic cancers altogether, the authors intended to highlight not only the overlapping mechanisms but also the distinct patterning of disease detection and progression as a means to uniquely treat each metastasis type. The scarcity of LMD cases poses a barrier to more robust evaluations of this pathology. However, as treatments for primary cancers have improved over time, so has the incidence of LMD. The increase in diagnosed cases only represents a small fraction of LMD-afflicted patients. More often than not, LMD is determined upon autopsy. The motivation behind this review stems from the increased capacity to study LMD in spite of scarcity or poor patient prognosis. In vitro analysis of leptomeningeal cancer cells has allowed researchers to approach this disease at the level of cancer subtypes and markers. We ultimately hope to facilitate the clinical translation of LMD research through our discourse.<\/jats:p>","DOI":"10.3390\/curroncol30060442","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T03:02:13Z","timestamp":1687230133000},"page":"5906-5931","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape"],"prefix":"10.3390","volume":"30","author":[{"given":"Andrew","family":"Nguyen","sequence":"first","affiliation":[{"name":"College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nguyen","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaferanmi T.","family":"Dada","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persis D.","family":"Desai","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C.","family":"Ricci","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil B.","family":"Godbole","sequence":"additional","affiliation":[{"name":"School of Medicine, Tulane University, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pierre","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-4080","authenticated-orcid":false,"given":"Brandon","family":"Lucke-Wold","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: Current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(06)70443-4","article-title":"Neoplastic meningitis","volume":"5","author":"Gleissner","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_3","unstructured":"Batool, A., and Kasi, A. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.21037\/apm-20-973","article-title":"An overview of leptomeningeal disease","volume":"10","author":"Nguyen","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6004\/jnccn.2023.0002","article-title":"NCCN Guidelines\u00ae Insights: Central Nervous System Cancers, Version 2.2022","volume":"21","author":"Horbinski","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/neuonc\/noz049","article-title":"A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases","volume":"21","author":"Prabhu","year":"2019","journal-title":"Neuro-Oncology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0009-9260(99)91181-9","article-title":"Imaging features of leptomeningeal metastases","volume":"54","author":"Collie","year":"1999","journal-title":"Clin. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"iv285","DOI":"10.1093\/annonc\/mdh941","article-title":"The diagnostic and therapeutic management of leptomeningeal carcinomatosis","volume":"15","author":"Pavlidis","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1212\/WNL.0000000000008751","article-title":"Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases","volume":"94","author":"Pluim","year":"2020","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1212\/WNL.0b013e31828f183f","article-title":"Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors","volume":"80","author":"Nayak","year":"2013","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01162-3","article-title":"Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma","volume":"24","author":"Yadugiri","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1016\/j.prro.2017.05.002","article-title":"Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment","volume":"7","author":"Gunther","year":"2017","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: A multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s00415-012-6488-4","article-title":"Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab","volume":"259","author":"Bot","year":"2012","journal-title":"J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2217\/imt-2019-0004","article-title":"Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient","volume":"12","author":"Wu","year":"2020","journal-title":"Immunotherapy"},{"key":"ref_16","first-page":"1","article-title":"Clinical response of central nervous system melanoma to anti-PD1 therapy in 2 melanoma patients","volume":"1","author":"Glitza","year":"2017","journal-title":"Arch. Immunol."},{"key":"ref_17","unstructured":"U.S. (2023). Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, Based on 2021 Submission Data (1999\u20132019), U.S. Department of Health and Human Services."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000455115","article-title":"Prognostic Markers and Histologic Subtypes in Patients with Meningeal Carcinomatosis in Breast Cancer","volume":"61","author":"Alnajar","year":"2017","journal-title":"Acta Cytol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10143-012-0446-6","article-title":"The shifting landscape of metastatic breast cancer to the CNS","volume":"36","author":"Quigley","year":"2012","journal-title":"Neurosurg. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-021-06246-z","article-title":"Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period","volume":"189","author":"Watanabe","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e21333","DOI":"10.1097\/MD.0000000000021333","article-title":"Evaluation of imaging findings and prognostic factors after whole-brain radiotherapy for carcinomatous meningitis from breast cancer: A retrospective analysis","volume":"99","author":"Okada","year":"2020","journal-title":"Medicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","article-title":"Meningeal carcinomatosis in breast cancer: Prognostic factors and outcome","volume":"104","author":"Cruz","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","article-title":"Survival of breast cancer patients with meningeal carcinomatosis","volume":"21","author":"Gauthier","year":"2010","journal-title":"Ann. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10549-009-0627-3","article-title":"Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue","volume":"123","author":"Park","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"vdab162","DOI":"10.1093\/noajnl\/vdab162","article-title":"Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis","volume":"3","author":"Tewarie","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2015.12.021","article-title":"Leptomeningeal metastasis: Clinical experience of 519 cases","volume":"56","author":"Hyun","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1158\/0008-5472.CAN-13-2051","article-title":"Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis","volume":"73","author":"Magbanua","year":"2013","journal-title":"Cancer Res"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mayrovitz, H.N. (2022). Breast Cancer, Exon Publications.","DOI":"10.36255\/exon-publications-breast-cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2741\/e765","article-title":"EGFR and HER2 signaling in breast cancer brain metastasis","volume":"8","author":"Sirkisoon","year":"2016","journal-title":"Front. Biosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1158\/0008-5472.CAN-12-1803","article-title":"Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases","volume":"73","author":"Zhang","year":"2013","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.18632\/oncotarget.2846","article-title":"Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines","volume":"6","author":"Momeny","year":"2015","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaoncol.2016.5630","article-title":"Intrinsic Subtype Switching and Acquired ERBB2\/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases","volume":"3","author":"Priedigkeit","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2015.11.022","article-title":"Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery","volume":"94","author":"Johnson","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3340\/jkns.2012.52.3.193","article-title":"Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases","volume":"52","author":"Jung","year":"2012","journal-title":"J. Korean Neurosurg. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11060-022-03977-x","article-title":"Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease","volume":"157","author":"Mills","year":"2022","journal-title":"J. Neuro-Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.49.11.1246","article-title":"Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer","volume":"49","author":"Twijnstra","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11060-020-03555-z","article-title":"Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer","volume":"148","author":"Malani","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jasc.2019.09.001","article-title":"Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis","volume":"9","author":"Torre","year":"2019","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1158\/1078-0432.CCR-20-3954","article-title":"Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases","volume":"27","author":"Angus","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-21-3017","article-title":"Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis","volume":"28","author":"Fitzpatrick","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","article-title":"Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis","volume":"17","author":"Morikawa","year":"2016","journal-title":"Clin. Breast Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11060-018-2790-z","article-title":"Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM)","volume":"138","author":"Pogoda","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"100150","DOI":"10.1016\/j.esmoop.2021.100150","article-title":"Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database","volume":"6","author":"Carausu","year":"2021","journal-title":"ESMO Open"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/neuonc\/noz201","article-title":"Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer","volume":"22","author":"Wallet","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/neuonc\/noac180","article-title":"Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis","volume":"25","author":"Oberkampf","year":"2022","journal-title":"Neuro-Oncology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1200\/JOP.19.00357","article-title":"Management of Brain Metastases in Non\u2013Small-Cell Lung Cancer","volume":"15","author":"Ernani","year":"2019","journal-title":"J. Oncol. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11864-021-00911-7","article-title":"Systemic Therapy for Lung Cancer Brain Metastases","volume":"22","author":"Pellerino","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","article-title":"Epidemiology of brain metastases and leptomeningeal disease","volume":"23","author":"Lamba","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fonc.2018.00278","article-title":"Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer","volume":"8","author":"Turkaj","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"22372","DOI":"10.1038\/s41598-022-26131-z","article-title":"Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e002473","DOI":"10.1136\/jitc-2021-002473","article-title":"Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: Efficacy, safety, and cerebrospinal fluid biomarkers","volume":"9","author":"Naidoo","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Fois, S.S., Paliogiannis, P., Zinellu, A., Fois, A.G., Cossu, A., and Palmieri, G. (2021). Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020612"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctro.2019.06.008","article-title":"EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis","volume":"18","author":"Mitra","year":"2019","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1470-2045(15)00614-2","article-title":"Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): Updated results from the multicentre, open-label, phase 1 trial","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1078-0432.CCR-22-1585","article-title":"Leptomeningeal Metastasis from Non\u2013Small Cell Lung Cancer and Current Landscape of Treatments","volume":"29","author":"Ozcan","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_58","first-page":"101417","article-title":"Invasion of small cell lung cancer into the limbic system from leptomeningeal metastases","volume":"33","author":"Higo","year":"2021","journal-title":"Respir. Med. Case Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chen, K.-C., Tsai, S.-W., Shie, R.-H., Zeng, C., and Yang, H.-Y. (2022). Indoor Air Pollution Increases the Risk of Lung Cancer. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19031164"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11864-020-00759-3","article-title":"Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations","volume":"21","author":"Alexander","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e13122","DOI":"10.15252\/emmm.202013122","article-title":"Mechanisms of small cell lung cancer metastasis","volume":"13","author":"Ko","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Niu, F.-Y., Zhou, Q., Yang, J.-J., Zhong, W.-Z., Chen, Z.-H., Deng, W., He, Y.-Y., Chen, H.-J., Zeng, Z., and Ke, E.-E. (2016). Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2169-5"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","article-title":"Progression and metastasis of lung cancer","volume":"35","author":"Popper","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2022.09.013","article-title":"Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment","volume":"174","author":"Wang","year":"2022","journal-title":"Lung Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2176\/jns-nmc.2022-0113","article-title":"Solitary Leptomeningeal Metastasis from Lung Cancer: A Case Report","volume":"9","author":"Yokawa","year":"2022","journal-title":"NMC Case Rep. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11910-022-01198-3","article-title":"Advances in the Diagnosis and Treatment of Leptomeningeal Disease","volume":"22","author":"Sharma","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, H., Xia, M., Zheng, S., Lin, Y., Yu, T., Xie, Y., Shen, Y., Liu, X., Qian, X., and Yin, Z. (2023). Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases. Biotechnol. Genet. Eng. Rev., 1\u201322.","DOI":"10.1080\/02648725.2023.2183613"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ajco.13759","article-title":"The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective","volume":"18","author":"Senko","year":"2022","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/fon-2021-0923","article-title":"MARIPOSA: Phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer","volume":"18","author":"Cho","year":"2022","journal-title":"Future Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/neuonc\/noaa152","article-title":"Clinical trial of proton craniospinal irradiation for leptomeningeal metastases","volume":"23","author":"Yang","year":"2020","journal-title":"Neuro-Oncology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era","volume":"53","author":"Remon","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ijc.30147","article-title":"Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy","volume":"139","author":"Smalley","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejca.2021.02.016","article-title":"Leptomeningeal disease from melanoma\u2014Poor prognosis despite new therapeutic modalities","volume":"148","author":"Chorti","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_75","unstructured":"Jasmine, J.O., and David, S. (2021). Neurology and General Medicine, Academic Press. [6th ed.]."},{"key":"ref_76","first-page":"79","article-title":"Metastatic Melanoma With Leptomeningeal Disease","volume":"12","author":"Marinova","year":"2021","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/pcmr.12172","article-title":"Why is melanoma so metastatic?","volume":"27","author":"Braeuer","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Rapanotti, M.C., Cugini, E., Nuccetelli, M., Terrinoni, A., Di Raimondo, C., Lombardo, P., Costanza, G., Cosio, T., Rossi, P., and Orlandi, A. (2021). MCAM\/MUC18\/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212416"},{"key":"ref_79","first-page":"2295","article-title":"Expression of MCAM\/MUC18 by human melanoma cells leads to increased tumor growth and metastasis","volume":"57","author":"Xie","year":"1997","journal-title":"Cancer Res."},{"key":"ref_80","first-page":"5106","article-title":"Fully human antibodies to MCAM\/MUC18 inhibit tumor growth and metastasis of human melanoma","volume":"62","author":"Mills","year":"2002","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/nly046","article-title":"Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease","volume":"77","author":"Ballester","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12032-013-0538-3","article-title":"Detection and quantification of CSF malignant cells by the CellSearch\u00ae technology in patients with melanoma leptomeningeal metastasis","volume":"30","author":"Tu","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/pcmr.12861","article-title":"Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions","volume":"33","author":"Glitza","year":"2020","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"867462","DOI":"10.3389\/fonc.2022.867462","article-title":"Karnofsky Performance Status (KPS) <\/=60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain Metastases","volume":"12","author":"Freeman","year":"2022","journal-title":"Front Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1200\/OP.20.00146","article-title":"Treatment of Metastatic Melanoma With Leptomeningeal Disease Using Intrathecal Immunotherapy","volume":"16","author":"Huppert","year":"2020","journal-title":"JCO Oncol. Pract."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1200\/JCO.2012.46.5773","article-title":"Vemurafenib for Leptomeningeal Melanomatosis","volume":"31","author":"Scheffler","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/CMR.0b013e32835e589c","article-title":"Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: A case report","volume":"23","author":"Lee","year":"2013","journal-title":"Melanoma Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/CMR.0000000000000257","article-title":"Vemurafenib in leptomeningeal carcinomatosis from melanoma: A case report of near-complete response and prolonged survival","volume":"26","author":"Floudas","year":"2016","journal-title":"Melanoma Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/cncr.33459","article-title":"Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies","volume":"127","author":"Bander","year":"2021","journal-title":"Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11060-017-2472-2","article-title":"Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient","volume":"133","author":"Glitza","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cncy.21502","article-title":"Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid","volume":"123","author":"Ho","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Burger, M.C., Zeiner, P.S., Jahnke, K., Wagner, M., Mittelbronn, M., and Steinbach, J.P. (2016). Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155315"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000485922","article-title":"Posterior Third Ventricular Glioblastoma with Primary Leptomeningeal Metastasis in a Child","volume":"53","author":"Demir","year":"2018","journal-title":"Pediatr. Neurosurg."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/01.coc.0000147409.01470.90","article-title":"Primary Presentation of Glioblastoma Multiforme With Leptomeningeal Metastasis in the Absence of Previous Craniotomy: A case report","volume":"27","author":"Pohar","year":"2004","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-010-0257-y","article-title":"Symptomatic spinal metastases of intracranial glioblastoma: Clinical characteristics and pathomechanism relating to GFAP expression","volume":"101","author":"Maslehaty","year":"2010","journal-title":"J. Neuro-Oncol."},{"key":"ref_96","first-page":"378","article-title":"Spinal leptomeningeal metastasis from cerebral glioblastoma: Case report","volume":"21","author":"Garcia","year":"2006","journal-title":"Neurologia"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-3019(01)00459-1","article-title":"Spinal leptomeningeal metastasis from cerebral glioblastoma multiforme presenting with radicular pain: Case report and literature review","volume":"56","author":"Alatakis","year":"2001","journal-title":"Surg. Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jocn.2011.09.024","article-title":"Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinal metastases, with two illustrative patients","volume":"19","author":"Shahideh","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jocn.2018.04.046","article-title":"Embryonal brain tumor with unknown primary lesion and massive cerebrospinal fluid dissemination: A case report","volume":"54","author":"Tanaka","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-014-0085-y","article-title":"Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma","volume":"2","author":"Jenkins","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-291","article-title":"ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma","volume":"13","author":"Phi","year":"2013","journal-title":"BMC Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ejca.2011.06.041","article-title":"MicroRNA-21 suppression impedes medulloblastoma cell migration","volume":"47","author":"Grunder","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00381-008-0697-2","article-title":"The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis","volume":"24","author":"Hsieh","year":"2008","journal-title":"Child\u2019s Nerv. Syst."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/ijpm.ijpm_817_21","article-title":"Pineocytoma with malignant transformation to pineal parenchymal tumor with intermediate differentiation and leptomeningeal dissemination after subtotal tumor resection and adjuvant radiotherapy","volume":"66","author":"Lieu","year":"2023","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/RLU.0000000000004368","article-title":"Primary Neuroendocrine Carcinoma of Pineal Gland With Extensive Meningeal Metastasis Detected by 18F-NOTATATE PET\/CT","volume":"47","author":"Deng","year":"2022","journal-title":"Clin. Nucl. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.29271\/jcpsp.2022.10.1347","article-title":"Symptomatic Spinal Seeding Metastasis of a Low-grade Oligodendroglioma","volume":"32","author":"Keskin","year":"2022","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10072-011-0769-z","article-title":"Symptomatic spinal cord metastasis from cerebral oligodendroglioma","volume":"33","author":"Elefante","year":"2011","journal-title":"Neurol. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1477-7819-12-265","article-title":"Leptomeningeal metastases from a primary central nervous system melanoma: A case report and literature review","volume":"12","author":"Pan","year":"2014","journal-title":"World J. Surg. Oncol."},{"key":"ref_109","first-page":"43","article-title":"Primary intracerebral malignant melanoma with leptomeningeal spread, extradural extension and lung metastasis","volume":"20","author":"Kobayashi","year":"2001","journal-title":"Clin. Neuropathol."},{"key":"ref_110","first-page":"1","article-title":"Intracerebral rhabdoid and papillary meningioma with leptomeningeal spread and rapid clinical progression","volume":"24","author":"Lach","year":"2005","journal-title":"Clin. Neuropathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.hoc.2019.08.020","article-title":"Hematologic Malignancies","volume":"34","author":"Tseng","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_112","first-page":"34","article-title":"Lymphoma: Diagnosis and Treatment","volume":"101","author":"Lewis","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.pop.2016.07.012","article-title":"Lymphoma","volume":"43","author":"Mugnaini","year":"2016","journal-title":"Prim. Care"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1756286418761697","DOI":"10.1177\/1756286418761697","article-title":"B cell-based therapies in CNS autoimmunity: Differentiating CD19 and CD20 as therapeutic targets","volume":"11","author":"Forsthuber","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.rcl.2008.03.005","article-title":"Overview of Lymphoma Diagnosis and Management","volume":"46","author":"Matasar","year":"2008","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1038\/bcj.2015.29","article-title":"Haematological cancer and quality of life: A systematic literature review","volume":"5","author":"Porro","year":"2015","journal-title":"Blood Cancer J."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Thandra, K.C., Barsouk, A., Saginala, K., Padala, S.A., Barsouk, A., and Rawla, P. (2021). Epidemiology of Non-Hodgkin\u2019s Lymphoma. Med. Sci., 9.","DOI":"10.3390\/medsci9010005"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"\u0160kunca, \u017d. (2020). B Cell Lymphomagenesis, IntechOpen.","DOI":"10.5772\/intechopen.87241"},{"key":"ref_119","unstructured":"Jamil, A., and Mukkamalla, S.K.R. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1182\/blood-2014-06-537514","article-title":"Brentuximab vedotin","volume":"124","author":"Ansell","year":"2014","journal-title":"Blood"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymeth.2020.06.020","article-title":"Functional imaging using radiomic features in assessment of lymphoma","volume":"188","author":"Mayerhoefer","year":"2020","journal-title":"Methods"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.14694\/EdBook_AM.2014.34.e388","article-title":"Surveillance Imaging for Lymphoma: Pros and Cons","volume":"34","author":"Lynch","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/01.wnl.0000435302.02895.f3","article-title":"Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report","volume":"81","author":"Taylor","year":"2013","journal-title":"Neurology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/0-387-24199-X_4","article-title":"Leptomeningeal Metastases from Leukemias and Lymphomas","volume":"125","author":"Nolan","year":"2005","journal-title":"Cancer Treat Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/0973-029X.294653","article-title":"Diagnosis of malignant lymphoma\u2014An overview","volume":"24","author":"Nirmal","year":"2020","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_127","first-page":"148","article-title":"Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin\u2019s Lymphoma","volume":"35","author":"Dotan","year":"2010","journal-title":"Pharm. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/blood-2010-09-308684","article-title":"Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system","volume":"117","author":"Baraniskin","year":"2011","journal-title":"Blood"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1034668","DOI":"10.3389\/fonc.2022.1034668","article-title":"Bruton\u2019s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review","volume":"12","author":"Shen","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_130","unstructured":"Chennamadhavuni, A., Lyengar, V., Mukkamalla, S.K.R., and Shimanovsky, A. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_131","first-page":"731","article-title":"Leukemia: An overview for primary care","volume":"89","author":"Davis","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43055-020-00337-5","article-title":"Role of magnetic resonance imaging in characterization of central nervous system lesions in pediatric patients with leukemia and post-treatment complications","volume":"51","author":"Amer","year":"2020","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"68","DOI":"10.21037\/atm-20-3140","article-title":"A narrative review of central nervous system involvement in acute leukemias","volume":"9","author":"Deak","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_134","first-page":"67","article-title":"Role of Stem-Cell Transplantation in Leukemia Treatment","volume":"13","author":"Dessie","year":"2020","journal-title":"Stem Cells Cloning: Adv. Appl."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/cncr.33477","article-title":"Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach","volume":"127","author":"Kantarjian","year":"2021","journal-title":"Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-018-0608-2","article-title":"BCL-2 as therapeutic target for hematological malignancies","volume":"11","author":"Perini","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41408-022-00687-5","article-title":"Resistance to targeted therapies: Delving into FLT3 and IDH","volume":"12","author":"Desikan","year":"2022","journal-title":"Blood Cancer J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and Management of Multiple Myeloma: A Review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: A unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_140","first-page":"470","article-title":"The Diagnosis and Treatment of Multiple Myeloma","volume":"113","author":"Gerecke","year":"2016","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1148\/rg.2019180096","article-title":"Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria","volume":"39","author":"Carneiro","year":"2019","journal-title":"Radiographics"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood-2018-08-825356","article-title":"Imaging in multiple myeloma: How? When?","volume":"133","author":"Zamagni","year":"2019","journal-title":"Blood"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JOP.19.00244","article-title":"Current Treatment Strategies for Multiple Myeloma","volume":"16","author":"Branagan","year":"2020","journal-title":"JCO Oncol. Pract."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2204925","article-title":"Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma","volume":"387","author":"Richardson","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3389\/fimmu.2020.01155","article-title":"Targeted Therapy With Immunoconjugates for Multiple Myeloma","volume":"11","author":"Bruins","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/17474086.2022.2084068","article-title":"BCMA-targeted therapies for multiple myeloma: Strategies to maximize efficacy and minimize adverse events","volume":"15","author":"Watson","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"12503","DOI":"10.1182\/blood-2022-163447","article-title":"How to Treat Isolated Leptomeningeal Relapse of Multiple Myeloma 11 Years after Autologous Stem Cell Transplantation (ASCT)","volume":"140","author":"Reynoso","year":"2022","journal-title":"Blood"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"bcr2014209160","DOI":"10.1136\/bcr-2014-209160","article-title":"Giant cell arteritis mimicking infiltrative leptomeningeal disease of the optic nerves","volume":"2015","author":"Kornberg","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2324709614529417","DOI":"10.1177\/2324709614529417","article-title":"Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report","volume":"2","author":"Fischer","year":"2014","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"9513576","DOI":"10.1155\/2020\/9513576","article-title":"Leptomeningeal Enhancement due to Neurosarcoidosis Mimicking Malignancy","volume":"2020","author":"Saltijeral","year":"2020","journal-title":"Case Rep. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis","volume":"3","author":"Ungprasert","year":"2019","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"13735","DOI":"10.1038\/s41598-021-92967-6","article-title":"Clinical characterization and outcomes of 85 patients with neurosarcoidosis","volume":"11","author":"Kostov","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Bergantini, L., Nardelli, G., D\u2019alessandro, M., Montuori, G., Piccioli, C., Rosi, E., Gangi, S., Cavallaro, D., Cameli, P., and Bargagli, E. (2022). Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series. J. Clin. Med., 11.","DOI":"10.3390\/jcm11072065"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00415-018-8928-2","article-title":"Sarcoidosis of the central nervous system: Clinical features, imaging, and CSF results","volume":"265","author":"Kidd","year":"2018","journal-title":"J. Neurol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ccr3.1418","article-title":"Not everything is as it seems: Neurosarcoidosis presenting as leptomeningitis","volume":"6","author":"Mercado","year":"2018","journal-title":"Clin. Case Rep."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/WCO.0000000000000684","article-title":"Management of neurosarcoidosis: A clinical challenge","volume":"32","author":"Voortman","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02341153","article-title":"Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias","volume":"9","author":"Kaplan","year":"1990","journal-title":"J. Neuro-Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"800053","DOI":"10.3389\/fonc.2021.800053","article-title":"Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD)","volume":"11","author":"Ferguson","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci. Transl. Med."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/6\/442\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:56:35Z","timestamp":1760126195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/6\/442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":160,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["curroncol30060442"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30060442","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]}}}